[HTML][HTML] 基于18F-FDG PET/CT 代谢参数构建非小细胞肺癌PD-L1 表达的列线图预测模型
HAO Luoluo, W Lifeng, M ZHANG… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
背景与目的近年来, 程序性细胞死亡受体1 (programmed cell death 1, PD-
1)/程序性细胞死亡配体1 (programmed cell death ligand 1, PD-L1) 免疫抑制剂为代表的免疫 …
1)/程序性细胞死亡配体1 (programmed cell death ligand 1, PD-L1) 免疫抑制剂为代表的免疫 …
Construction of A Nomogram Prediction Model for PD-L1 Expression in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters
L Hao, L Wang, M Zhang, J Yan… - Zhongguo fei ai za zhi …, 2023 - europepmc.org
In recent years, immunotherapy represented by programmed cell death 1 (PD-
1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly changed the …
1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly changed the …
Construction of A Nomogram Prediction Model for PD-L1 Expression in Non-small Cell Lung Cancer Based on 18F-FDG PET/CT Metabolic Parameters.
HAO Luoluo, W Lifeng, M ZHANG… - Chinese Journal of …, 2023 - search.ebscohost.com
Background and objective In recent years, immunotherapy represented by programmed cell
death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly …
death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunosuppressants has greatly …
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography …
DJ Hughes, E Josephides, R O'Shea… - European …, 2024 - Springer
Background Programmed death-ligand 1 (PD-L1) expression is a predictive biomarker for
immunotherapy in non-small cell lung cancer (NSCLC). PD-L1 and glucose transporter 1 …
immunotherapy in non-small cell lung cancer (NSCLC). PD-L1 and glucose transporter 1 …
PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
X Wu, Y Huang, Q Zhao, L Wang, X Song, Y Li… - EJNMMI research, 2020 - Springer
Background Immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-
L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring …
L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring …
Current challenges with PD-L1 testing for immunotherapy biomarkers in non-small cell lung cancer
Y Li, J Chen - Zhonghua bing li xue za zhi= Chinese …, 2019 - pubmed.ncbi.nlm.nih.gov
近年来, 免疫疗法已逐渐成为多种肿瘤的重要治疗策略之一, 其中免疫检查点程序性死亡分子
(PD-1) 及其配体 (PD-L1) 备受关注. PD-L1 是目前最常用的免疫疗效预测生物标志物之一. PD …
(PD-1) 及其配体 (PD-L1) 备受关注. PD-L1 是目前最常用的免疫疗效预测生物标志物之一. PD …
[HTML][HTML] Value of 18F-FDG PET/CT Based on PD-L1 to Predict Outcomes of Immunotherapy in NSCLC
F Xie, M Li, X Jing - Advances in Bioscience and Biotechnology, 2023 - scirp.org
Immune checkpoint inhibitors (ICIs), targeting programmed cell death protein-1 (PD-1) and
its ligand (PD-L1), have changed the treatment history of lung cancer, especially in the field …
its ligand (PD-L1), have changed the treatment history of lung cancer, especially in the field …
[HTML][HTML] Prognostic significance of PD-L1 expression and 18F-FDG PET/CT in surgical pulmonary squamous cell carcinoma
M Zhang, D Wang, Q Sun, H Pu, Y Wang, S Zhao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Programmed cell death-ligand 1 (PD-L1) expression is commonly observed in non-small
cell lung cancer (NSCLC). The prognostic value of PD-L1 expression and the maximum …
cell lung cancer (NSCLC). The prognostic value of PD-L1 expression and the maximum …
Combining PD-L1 expression and standardized uptake values in FDG-PET/CT can predict prognosis in patients with resectable non–small-cell lung cancer
T Miyazawa, K Otsubo, H Sakai, H Kimura… - Cancer …, 2021 - journals.sagepub.com
Background This study aimed to determine the relationship of programmed death-ligand 1
(PD-L1) expression and standardized uptake values in fluorodeoxyglucose–positron …
(PD-L1) expression and standardized uptake values in fluorodeoxyglucose–positron …
The correlation between PD-L1 expression and metabolic parameters of 18FDG PET/CT and the prognostic value of PD-L1 in non-small cell lung cancer
X Xu, J Li, Y Yang, S Sang, S Deng - Clinical Imaging, 2022 - Elsevier
Objectives In the present study, we aimed to investigate the relationship between metabolic
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …